Category Archives: Recalled Drugs

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Class III Voluntary Recall Issued for High Blood Pressure Medication

Class III Recall Issued for High Blood Pressure Medication

As a result of a recent Enforcement Report of the U.S. Food and Drug Administration (FDA), Sun Pharma and Lupin  are recalling over 41.5 thousand drug bottles in the United States. Sun Pharmaceutical Industries Inc. is recalling 12,109 bottles of … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Teva Pharmaceuticals Initiates Voluntary Recall due to Potential Glass Particulate Matter

Teva Pharmaceuticals Initiates Voluntary Recall due to Glass

Teva Pharmaceuticals based in North Wales, Pennsylvania, announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL and 1 tram/4mL vials as a result of the potential presence of glass particulate matter. Amikacin Sulfate Injection is used … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

Lawsuits Increasing in the US and Canada with Risks of Xarelto Use

The blood thinner Xarelto (rivaroxaban) is a relatively new anticoagulant that has gained popularity through its convenience of use for the patient. Warfarin, also known as Coumadin, the established anticoagulant for the last 60 years, requires dietary restrictions and a … Continue reading

Posted in Health Concerns, Recalled Drugs |

Children’s Cough Syrups Recalled Because of Incorrect Dosing Cup

cough-Syrup

Perrigo Company of Dublin, Ireland, has initiated a voluntary recall of five batches of its children’s cough syrups because some packages contain an oral dosing cup with incorrect dose markings and children could receive an overdose of the medicine. The … Continue reading

Posted in Health Concerns, Pharmaceuticals, Recalled Drugs | Tagged , , , , |

Florida Pharmacy Recalls Multivitamin Capsules that May Cause Vitamin D Toxicity

The Food and Drug Administration (FDA) has alerted health care providers and patients to a voluntary recall of compounded multivitamin capsules containing high amounts of vitamin D3 (cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. The FDA has received … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Infant Death Triggers FDA Warning About Probiotic Dietary Supplements

The Food and Drug Administration (FDA) has formally warned healthcare providers about using dietary supplements containing live bacteria or yeast in patients with compromised immune systems. The warning explains that dietary supplements are not regulated in the United States as approved … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Sun Pharmaceutical’s Effexor Recalled for the Second Time This Year

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor (venlafaxine), in the second recall of the drug this year, the Food and Drug Administration (FDA) said. In both instances, the recalled drug was manufactured at the Indian … Continue reading

Posted in Defective Products, Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA: All Non-Expired Sterile Unique Pharmaceuticals’ Drugs Recalled

The U.S. Food and Drug Administration (FDA) advised that it is alerting health care professionals and consumers regarding a recall of all non-expired drug products meant for sterile use and sold and distributed by Unique Pharmaceuticals Ltd., located in Temple, … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA Announces Recall of Generic Versions of Heart Drug Toprol XL

Just a few months after one generic version of a popular extended-release blood pressure medication was recalled, a lot of metoprolol succinate from another manufacturer was recalled for the same reason:  the drug did not dissolve properly. The recalled drugs, … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Indian Drugmaker Sun Pharma Recalls 400,000 Bottles of Two Drugs

Sun Pharma, India’s largest drugmaker, has announced the recall of almost 400,000 bottles of anti-depressant and antihistamine medications in the U.S. because the pills failed to dissolve properly. About 128,000 bottles of Sun Pharma’s antihistamine cetirizine, known by the brand … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.